[ad_1]
An Alaskan healthcare worker suffered a severe allergic reaction after receiving the COVID-19 vaccine from Pfizer-BioNTech and is now hospitalized but stable, according to a report released Wednesday.
The New York Times reported that the person received his dose on Tuesday, while Pfizer confirmed that it was working with local authorities to investigate the incident.
“We do not yet have full details of Alaska’s report on possible serious allergic reactions, but we are actively working with local health authorities to assess. the case, said a Pfizer spokesman.
“We will closely monitor all reports suggesting serious allergic reactions after vaccination and update the label text if necessary,” he added.
The volunteers who showed up to Pfizer clinical trial, which enrolled 44,000 people, were excluded if they had a history of allergic reactions to vaccines or components of the immunizer against COVID-19.
Overall, the trial found no serious safety concerns, but regulators and the company continue to monitor adverse cases after vaccination.
Two healthcare workers in Britain had similar allergic reactions, which caused the government of the European nation to recommend to the population that avoid getting the vaccine if they had a history of severe allergies.
The US Food and Drug Regulator, The FDA issued an emergency approval for the immunizer with the caveat that people who have experienced allergies to the ingredients within the vaccine should avoid it.
The United States this week began applying this vaccine to about three million people and hopes to reach a total of 20 million people this month if another immunizer is approved, the one developed by the American laboratory Moderna.
[ad_2]
